Genome sequencing of tumors biopsied from women with invasive breast cancer

[News]

Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.

More... (http://www.news-medical.net/news/20100327/Genome-sequencing-of-tumors-biopsied-from-women-with-invasive-breast-cancer.aspx)